Business Wire

ACRE-IMPACT-CAPITAL

17.4.2024 09:04:29 CEST | Business Wire | Press release

Share
Acre Impact Capital Announces the First Closing of its Export Finance Fund I

Acre Impact Capital, a private-debt impact investment manager announces the first closing of its Export Finance Fund I (the “Fund”), with commitments of ~US$100mn, with a target size of US$300mn.

The Fund has attracted a diverse group of investors including institutional investors, major Development Finance Institutions (DFIs), family offices and impact-first investors such as Trimtab Impact and Ceniarth. DFIs include the European Investment Bank and FSD Africa Investments. The Fund has also secured significant commitments from several African investors, reflecting the attractive risk-return profile and expected impact of the strategy.

Addressing the urgent need for climate infrastructure investment

Acre Impact Capital’s innovative Export Finance Fund I is the first fund of its kind leveraging the transaction facilitation role of export credit agencies (“ECAs”) for impact. Export finance delivers long-term debt financing guaranteed by official ECAs, allowing project sponsors to significantly reduce the cost of debt by obtaining attractive funding on ECA-backed financing and extending tenors up to 22 years. In doing so, ECAs significantly enhance project affordability and crowd-in private capital.

The Fund addresses a critical financing gap for African climate-aligned infrastructure. While commercial banks typically fund the tranche guaranteed by an ECA (worth 85% of the project value), funding for the remaining 15% commercial debt tranche has been increasingly scarce. By providing specialist funding for this tranche, the Fund will unlock transactions and mobilise $5.6 of private sector capital for each dollar invested.

“We are incredibly proud to have received support from our limited partners, who have backed our pioneering Export Finance Fund I. The current credit environment creates attractive opportunities for discerning investors, while addressing the urgent need for funding for climate-aligned infrastructure projects.” said Hussein Sefian, CEO of Acre Impact Capital. “The Fund aims to invest in 15-20 projects in four thematic areas: (i) Renewable Power; (ii) Health, Food and Water Scarcity; (iii) Sustainable Cities and (iv) Green Transportation. These projects will deliver significant environmental and social impact while providing investors with desirable diversification.”

Commitment to 2X Challenge

The Fund is committed to gender smart investing and seeks to ensure at least 30% of its portfolio of projects meet the 2X Criteria, increasing the number of women represented across its investment portfolio. In addition, Acre Impact Capital commits to promote and maintain gender balance at the fund manager and creating a culture that values diversity and inclusion.

Acre Impact Capital is a recipient of Technical Assistance from United States Agency for International Development (USAID)'s Scaling-Up Renewable Energy (SURE) programme to support the integration of the gender equality and social inclusion in its investment processes.

About Acre Impact Capital

Acre Impact Capital invests in climate-aligned essential infrastructure by partnering with leading commercial lenders and export credit agencies. Acre Impact Capital’s Export Finance Fund I addresses the estimated $100 billion annual infrastructure financing gap in Africa, driving economic growth and providing essential services for underserved populations.

Acre Impact Capital’s development was supported by funding provided by the Private Infrastructure Development Group’s (PIDG) Technical Assistance, through PIDG Company GuarantCo. PIDG is an innovative finance organisation funded by the governments of the UK, the Netherlands, Switzerland, Australia, Sweden, Germany and the IFC. Support for the design and development of the Fund was provided by The Rockefeller Foundation.

Website: https://www.acre.capital/
LinkedIn: https://www.linkedin.com/company/acre-impact-capital

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

View source version on businesswire.com: https://www.businesswire.com/news/home/20240417910656/en/

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com
DK

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

The LYCRA Company Appoints Hua Du as Chief Executive Officer15.9.2026 14:00:00 CEST | Press release

The LYCRA Company, a global leader in developing fiber and technology solutions for the apparel and personal care industries, announced today that Hua Du has been appointed chief executive officer, effective September 14, as the company enters its next chapter following the successful completion of its financial restructuring. Du succeeds Dean Williams, who served as interim chief executive officer and will continue in his role as chief financial officer. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260915565505/en/ The LYCRA Company Appoints Hua Du as Chief Executive Officer. With 30 years of leadership experience in the specialty chemical and biotechnology industries, Du is well positioned to lead the company into its next chapter. Du brings 30 years of leadership experience in the specialty chemical and biotech-based industries, driving transformational growth across global businesses. Du most recently served as CEO of

Visa, Circle and Haun Ventures Back Velocity in Series A Extension, Bringing Total Series A Funding to $48 million15.9.2026 14:00:00 CEST | Press release

Velocity, the stablecoin payments and treasury platform, today announced a $10 million extension to its Series A, with investment from Visa Ventures, Circle Ventures, Ripple, Haun Ventures, Translink Capital and Mirana Ventures. The extension follows Velocity’s $38 million Series A announced last month and will support the company’s work to bring stablecoin infrastructure to issuers, acquirers, payment providers, financial institutions and merchants worldwide. “We are excited to welcome several new investors to Velocity, including Visa through Visa Ventures,” said Eric Queathem, founder and CEO of Velocity. “From day one, we have focused on improving how money moves through the payments ecosystem. These investors operate at the center of that ecosystem and will provide invaluable insight as we use stablecoins to transform the experience.” Velocity is building infrastructure that enables institutions and businesses to use stablecoins for settlement, liquidity and treasury operations wit

Riskified Brings Identity Risk Intelligence to Zendesk, Helping Retailers Stop Returns Fraud Without Sacrificing Customer Experience15.9.2026 14:00:00 CEST | Press release

Riskified Identity Risk Intelligence equips Zendesk Industry Agents with insights drawn from billions of orders, claims, and chargebacks, helping retailers identify abuse and resolve legitimate claims with confidence Riskified (NYSE: RSKD), a global leader in ecommerce fraud detection and risk intelligence, today announced a new partnership with Zendesk that brings its Identity Risk Intelligence directly into Zendesk’s customer service workflow. The integration gives human and AI support agents real-time signals, helping retailers resolve legitimate claims faster while curbing returns and refund abuse that drains revenue. According to the National Retail Federation, U.S. retailers saw $849.9 billion in returns in 2025, approximately 9% of which were fraudulent. Based on those figures, Riskified calculates that return fraud costs U.S. retailers approximately $76.5 billion, and the losses are far higher when accounting for global returns fraud. Shoppers admit it too: one in four acknowle

Ori Biotech Announces 10-year, $120M Partnership to Advance Automated Manufacturing for Commercial Cell Therapies15.9.2026 14:00:00 CEST | Press release

Collaboration to switch a commercial cell therapy onto the IRO® platform for an undisclosed pharma partner Oribiotech Ltd. (Ori), a leader in advanced cell and gene therapy (CGT) manufacturing technology, today announced a strategic collaboration with an undisclosed biopharmaceutical company to integrate the IRO® platform into a commercial cell therapy manufacturing process in a deal valued at up to $120M in services, milestones, equipment and consumable purchases over the next 10 years. The collaboration is designed to modernize the partner’s autologous cell therapy manufacturing infrastructure with the aim of expanding patient access to current and future potentially transformative cell therapies. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260915757436/en/ The IRO platform Autologous cell therapies, manufactured from a patient's own cells, require precise, reliable and scalable manufacturing processes. Meeting that req

Vertex Partners With World Champion Skier Lindsey Vonn to Raise Awareness of JOURNAVX®, a Non-Opioid Medicine Approved for the Treatment of Moderate-to-Severe Acute Pain15.9.2026 13:30:00 CEST | Press release

- Vonn shares her experience using JOURNAVX to manage her acute pain after a career-altering injury at the 2026 Winter Games - Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that the company has partnered with world champion skier Lindsey Vonn to raise awareness of JOURNAVX® (suzetrigine), a prescription non-opioid medicine for the treatment of moderate-to-severe acute pain in adults. Approved by the U.S. Food and Drug Administration (FDA) in January 2025, JOURNAVX marked the first new class of pain medicine in over 20 years — since then JOURNAVX has been prescribed to over one million Americans. During the 2026 Winter Games in Milano Cortina, Lindsey suffered a serious crash during her downhill race. The fall resulted in multiple injuries that required immediate surgery and several additional procedures. Now, Lindsey is sharing her story and her personal experience treating her moderate-to-severe acute pain with JOURNAVX. “I have experienced countless injuries thro

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye